🔹 Fixed Assets & Borrowings – How are capital investments and leverage impacting the sector?
🔹 Shareholding Pattern – Are promoters, FIIs, and DIIs increasing or decreasing their stake?
🔹 Reserves & Revenue Growth – Are companies showing strong financial health?
🔹 EBITDA Margins – What do profitability trends indicate?
The value migration in the pharma sector is at an interesting stage. R&D investments, API self-sufficiency, and global supply chain diversification are shaping long-term growth. 📈
What’s your take on this? Share your views in the comments! 👇
